Science & Enterprise subscription

Follow us on Twitter

  • Another way to connect 100 million people end-to-end with Covid-19 vaccines. https://t.co/wIWk0XNDhv
    about 12 hours ago
  • New post on Science and Enterprise: Celebrating the New Administration https://t.co/5ErPGhVDEN #Science #Business
    about 19 hours ago
  • A company applying Crispr gene-editing technology to treat inherited heart disease is raising $94 million in its se… https://t.co/2QgwrBLIQd
    about 2 days ago
  • New post on Science and Enterprise: Crispr Heart Disease Biotech Raises $94M in New Funds https://t.co/XJHC82ALY3 #Science #Business
    about 2 days ago
  • A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical tri… https://t.co/ZkSq0jOpmg
    about 2 days ago

Please share Science & Enterprise

Stem Cell Therapy Results Reported for Spinal Cord Injury

Model of spine (NIH)

(NIH)

Researchers for StemCells Inc. in Newark, California reported interim, largely positive, results from a clinical trial of stem cell therapy to treat spinal cord injury. The findings were reported yesterday at a meeting of the International Spinal Cord Society in London.

The trial tests StemCells’ therapy to treat disorders of the central nervous system, called HuCNS-SC, conducted at the Spinal Cord Injury Center at Balgrist University Hospital, part of University of Zurich. The study, a phase 1/phase 2 trial, tests the safety, tolerability, and preliminary efficacy of the treatments on patients with thoracic — chest level — spinal cord trauma, where there is no neurological function below the level of injury.

At the International Spinal Cord Society meeting, Armin Curt of Balgrist hospital, who is leading the trial said, “two of the three patients have gained considerable sensory function. The gains in sensation have evolved in a progressive pattern below the level of injury and are unanticipated in spinal cord injury patients with this severity of injury, suggesting that the neural stem cells are having a beneficial clinical effect.”

Curt continued, “Sensory function of all these patients was stable before transplantation, so the reappearance of sensation is rather unexpected.” He added that “these three patients have tolerated the cell transplantation very well, and we have no safety concerns at this point.”

HuCNS-SC consists of purified human neural stem cells. The company says the three patients were transplanted four to nine months after injury with a dose of 20 million cells at the site of injury. The company says the surgery, immunosuppression, and cell transplants were well tolerated by the patients.

Stephen Huhn, vice-president of StemCells Inc. says, “To our knowledge, this is the first time a sensory change of this magnitude has been reported in patients with complete spinal cord injury following a stem cell transplantation.  We clearly need to collect more data to establish efficacy, but we are encouraged.”

Read more:

Hat tip: Med City News

*     *     *

2 comments to Stem Cell Therapy Results Reported for Spinal Cord Injury